Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

AGLE Aeglea BioTherapeutics

Watchlist
0.520
+0.016+3.17%
Close  02/06 16:00 ET
0.500
-0.020-3.85%
Pre Mkt Price 02/07 05:28 ET
High
0.528
Open
0.495
Turnover
113.10K
Low
0.495
Pre Close
0.504
Volume
219.09K
Market Cap
31.99M
P/E(TTM)
Loss
52wk High
3.540
Shares
61.51M
P/E(Static)
Loss
52wk Low
0.340
Float Cap
16.78M
Bid/Ask %
-11.11%
Historical High
12.750
Shs Float
32.27M
Volume Ratio
1.03
Historical Low
0.340
Dividend TTM
--
Div Yield TTM
--
P/B
0.47
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.68%
Amplitude
6.57%
Avg Price
0.516
Lot Size
1
Float Cap
16.78M
Bid/Ask %
-11.11%
Historical High
12.750
Shs Float
32.27M
Volume Ratio
1.03
Historical Low
0.340
Dividend TTM
--
P/B
0.47
Dividend LFY
--
Turnover Ratio
0.68%
Amplitude
6.57%
Avg Price
0.516
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Aeglea Biotherapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe in December 2013 and is headquartered in Austin, TX.
CEO: Mr. Jeffrey M. Goldberg
Market: NASDAQ
Listing Date: 04/07/2016
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist